CRIPTO’s Multifaceted Role in Driving Aggressive Prostate Cancer Unveiled by In Vivo, Organoid, and Patient Data

Scientists demonstrated that suppressing Cripto in vivo significantly decreased invasive cell behavior in aggressive tumors, highlighting a critical oncogenic function of CRIPTO in advanced prostate cancer.